Protective potential of klotho protein on diabetic retinopathy: Evidence from clinical and in vitro studies
- PMID: 31197979
- PMCID: PMC6944830
- DOI: 10.1111/jdi.13100
Protective potential of klotho protein on diabetic retinopathy: Evidence from clinical and in vitro studies
Abstract
Aims/introduction: The purpose of the present study was to observe the relationship between serum α-klotho (KL) protein level and diabetic retinopathy (DR), and to further examine the effects of KL protein on apoptosis induced by palmitic acid (PA) in human retinal endothelial cells.
Materials and methods: A total of 17 healthy people and 60 type 2 diabetes patients were included. According to the results from fundus fluorescein angiography, the diabetes patients were divided into three subgroups: without DR, non-proliferative DR and proliferative DR. Serum KL level was measured by enzyme-linked immunosorbent assay. In vitro, human retinal endothelial cells were exposed to PA with or without KL protein. Apoptosis rates were analyzed by flow cytometry analysis. Apoptotic-related protein expressions were detected by western blotting analysis.
Results: Serum KL level was lower in diabetes patients than that in healthy participants (P = 0.007), and was gradually decreased among the without DR, non-proliferative DR and proliferative DR subgroups (P = 0.045). A logistic regression analysis showed that after adjusting for the other confounding factors, serum KL level was independently and negatively related with DR (P = 0.049). Furthermore, the increased apoptosis rates induced by PA were inhibited with the addition of KL protein. Consistently, KL protein reversed the expression levels of the increased pro-apoptotic protein Bax and the decreased anti-apoptotic protein Bcl-2 induced by PA. However, the anti-apoptotic effect of KL protein was attenuated by LY294002 through the phosphatidylinositol 3 kinase-serine∕threonine kinase pathway.
Conclusions: The data suggested that KL protein was probably a potential protective factor against retinopathy in type 2 diabetes patients.
Keywords: Apoptosis; Diabetic retinopathy; α-Klotho.
© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Figures




Similar articles
-
Klotho: A new therapeutic target in diabetic retinopathy?World J Diabetes. 2023 Jul 15;14(7):1027-1036. doi: 10.4239/wjd.v14.i7.1027. World J Diabetes. 2023. PMID: 37547589 Free PMC article. Review.
-
α-Klotho prevents diabetic retinopathy by reversing the senescence of macrophages.Cell Commun Signal. 2024 Sep 26;22(1):449. doi: 10.1186/s12964-024-01838-w. Cell Commun Signal. 2024. PMID: 39327553 Free PMC article.
-
The KL-VS polymorphism of KLOTHO gene is protective against retinopathy incidence in patients with type 1 diabetes.Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):758-763. doi: 10.1016/j.bbadis.2017.12.015. Epub 2017 Dec 13. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29247834
-
The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.J Ethnopharmacol. 2020 Jun 12;255:112773. doi: 10.1016/j.jep.2020.112773. Epub 2020 Mar 18. J Ethnopharmacol. 2020. PMID: 32199990
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
Cited by
-
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.Biores Open Access. 2020 Mar 31;9(1):94-105. doi: 10.1089/biores.2020.0004. eCollection 2020. Biores Open Access. 2020. PMID: 32257625 Free PMC article. Review.
-
Klotho: A new therapeutic target in diabetic retinopathy?World J Diabetes. 2023 Jul 15;14(7):1027-1036. doi: 10.4239/wjd.v14.i7.1027. World J Diabetes. 2023. PMID: 37547589 Free PMC article. Review.
-
Recombinant human klotho protects against hydrogen peroxide-mediated injury in human retinal pigment epithelial cells via the PI3K/Akt-Nrf2/HO-1 signaling pathway.Bioengineered. 2022 May;13(5):11767-11781. doi: 10.1080/21655979.2022.2071023. Bioengineered. 2022. PMID: 35543385 Free PMC article.
-
Relationship of fibroblast growth factor 21, Klotho, and diabetic retinopathy: a meta-analysis.Front Endocrinol (Lausanne). 2024 Aug 27;15:1390035. doi: 10.3389/fendo.2024.1390035. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39257905 Free PMC article.
-
Klotho's impact on diabetic nephropathy and its emerging connection to diabetic retinopathy.Front Endocrinol (Lausanne). 2023 Apr 18;14:1180169. doi: 10.3389/fendo.2023.1180169. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37143722 Free PMC article. Review.
References
-
- Leasher JL, Bourne RR, Flaxman SR, et al Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta‐analysis from 1990 to 2010. Diabetes Care 2016; 39: 1643–1649. - PubMed
-
- Lin S, Gupta B. Visual impairment certification due to diabetic retinopathy in North and Eastern Devon. Acta Ophthalmol 2017; 95: e756–e762. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials